It is a safe alternative to hGH that does not carry the risk of diabetes or insulin resistance
doi: 10.1016/j.molmet.2012.08.007 242 ZhangYXieYBerglundEDCoateKCHeTTKatafuchiTet al
Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of drugs that reduce blood sugar and energy intake by activating the GLP-1 receptor
Those with known glutathione allergy or sulfite sensitivity: Though rare, if youve had a bad reaction to glutathione in the past (or to N-acetylcysteine, a related compound), you should not risk an IV push
No other disease has to take on the kind of scrutiny that obesity takes on. The Alliance for Womens Health and Prevention has launched a nationwide effort with a coalition of other health advocacy groups called Everybody Covered to push policymakers to improve coverage of GLP-1 drugs and other obesity treatments
Iron chelators, while capable of reducing brain iron, risk systemic side effects by failing to discriminate between pathological iron accumulation and physiological iron requirements